Clinique de la Mémoire de l'Outaouais

Gatineau, Quebec K1Z 1G3

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Alzheimer Disease (AD), Brain Diseases, Central Nervous System Diseases, Cognitive Impairment, Dementia

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT) — Completed
• A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease — Completed